UCHL1 and Alzheimer disease: Higher levels of plasma UCH-L1 have been associated with PD (Ng et al., 2020), AD (Bogdan et al., 2022), Friedreich’s Ataxia (Zeitlberger et al., 2018), TBI (Wang et al., 2018), and general cognitive capabilities (Zhang et al., 2022a).